WeChat 'Yueya' app support for people on maintenance hemodialysis
Official title: Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
Run by First Affiliated Hospital of Chongqing Medical University · NCT07291154 · Data updated 2026-11-12
This project will test whether the 'Yueya' mini-program on WeChat helps people on maintenance hemodialysis follow treatment, feel better, and have fewer complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 392 (estimated) |
| Sponsor | First Affiliated Hospital of Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing, Chongqing Municipality) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 18, 2025 |
| Trial ID | NCT07291154 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 with stage 5 chronic kidney disease receiving regular maintenance hemodialysis (three times weekly for >3 months), who are relatively stable, able to self-care, and can use WeChat and the 'Yueya' mini-program.
✕Probably not a fit
Patients with recent major cardiovascular or cerebrovascular events, severe liver disease, active tuberculosis or AIDS, communication or cognitive barriers, or who cannot or will not use WeChat are unlikely to benefit from this app-based approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial randomizes maintenance hemodialysis patients to receive routine care or additional APP-based management delivered via the 'Yueya' mini-program on WeChat, which provides personalized health education, diet and exercise guidance, medication reminders, and condition monitoring. Clinical and laboratory indicators, cardiovascular events, hospitalizations, death, treatment compliance, and patient-reported quality of life will be recorded and compared between groups. The intervention aims to strengthen quality control in the hemodialysis unit and improve individual prognosis through enhanced self-management and clinician oversight. The study is conducted at The First Affiliated Hospital of Chongqing Medical University.
Why it matters
Potential benefit: If successful, the app-based program could improve treatment adherence, quality of life, and reduce hospitalizations and cardiovascular events for people on maintenance hemodialysis.
How similar studies have gone: Other digital health and app-based interventions in dialysis populations have shown improvements in adherence and quality of life in some trials, but results have been mixed and this specific 'Yueya' approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years old, and have regular dialysis three times a week. * Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study. * Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study. Exclusion Criteria: * Patients with communication barriers or other conditions that prevent them from cooperating with the study. * Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months. * Patients who are not willing to actively cooperate with the study. * Patients with severe liver cirrhosis, active tuberculosis and AIDS.
Where it's running
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China Recruiting
Study contacts
- Study coordinator: Yunfeng Xia Dr
- Email: yunfengxia0920@126.com
- Phone: 86-023-89012687
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Omnisol-preserved kidneys before transplant (hypothermic machine perfusion)
This study tests whether using Omnisol during hypothermic machine perfusion before kidney transplant can improve early graft function compared with standard preservation.
-
Remote monitoring in dialysis: comparing RPM-APD, manual PD, and maintenance HD
This study tests how well three dialysis approaches work for adults with ESRD starting dialysis in China, using real-world data from routine care.
-
Effect of pHA130 Hemoadsorption with Hemodialysis in Kidney Failure
Aims to see if adding the pHA130 hemoadsorption cartridge to dialysis helps reduce protein-bound toxins in people with end-stage kidney failure on maintenance dialysis.
-
Extra Ultrafiltration to Remove Fluid in Hemodialysis Patients
This trial tests whether adding extra ultrafiltration over 4 or 8 weeks helps people on in-center hemodialysis reduce excess body fluid and lower blood pressure.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Comparing physical therapy during dialysis versus before dialysis for adults on hemodialysis
This project tests whether supervised exercises done during dialysis or before dialysis help adults on hemodialysis improve physical function, quality of life, and blood measures like hemoglobin and electrolytes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.